ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chroni
Go back to ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chroni| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 78.85 +2.71 (3.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.14 | 52 Week High | $70.92 | |||
| Open | $75.50 | 52 Week Low | $26.80 | |||
| Day High | $79.43 | P/E | N/A | |||
| Day Low | $75.00 | EPS | $-0.96 | |||
| Volume | 579,335 | |||||
| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 78.85 +2.71 (3.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.14 | 52 Week High | $70.92 | |||
| Open | $75.50 | 52 Week Low | $26.80 | |||
| Day High | $79.43 | P/E | N/A | |||
| Day Low | $75.00 | EPS | $-0.96 | |||
| Volume | 579,335 | |||||

